Clinical and patient reported outcomes in multiple sclerosis patients on disease modifying therapies

被引：0
|
作者：
Fernandes, L. [1 ]
Horton, M. [2 ]
Russell, M. [1 ]
Lily, O. [1 ]
Ford, H. L. [1 ]
机构：
[1] Leeds Teaching Hosp NHS Trust, Leeds Ctr Neurosci, Leeds, W Yorkshire, England
[2] Univ Leeds, Leeds, W Yorkshire, England
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P812
引用
收藏
页码：417 / 418
页数：2
相关论文
共 50 条
  • [1] Patient-reported effects of disease-modifying therapies on employment outcomes in people with multiple sclerosis
    Chen, Jing
    Taylor, Bruce
    van der Mei, Ingrid
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (13) : NP21 - NP21
  • [2] Patient education on disease modifying therapies in multiple sclerosis
    Chrysovitsanou, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 136 - 136
  • [3] Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis
    Hiangkiat Tan
    Qian Cai
    Sonalee Agarwal
    Judith J. Stephenson
    Siddhesh Kamat
    Advances in Therapy, 2011, 28 : 51 - 61
  • [4] Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis
    Tan, Hiangkiat
    Cai, Qian
    Agarwal, Sonalee
    Stephenson, Judith J.
    Kamat, Siddhesh
    ADVANCES IN THERAPY, 2011, 28 (01) : 51 - 61
  • [5] Evolution of Visual Outcomes in Clinical Trials for Multiple Sclerosis Disease-Modifying Therapies
    Nolan, Rachel C.
    Akhand, Omar
    Rizzo, John-Ross
    Galetta, Steven L.
    Balcer, Laura J.
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2018, 38 (02) : 202 - 209
  • [6] Demographic, clinical and patient-reported characteristics of patients on ocrelizumab versus other disease-modifying therapies in the Corrona Multiple Sclerosis Registry
    Kantor, Daniel
    Engmann, Natalie J.
    Malley, Wendi
    McLean, Robert
    Cronin, Angel
    Dube, Blessing
    Miller, Aaron
    NEUROLOGY, 2020, 94 (15)
  • [7] BASELINE RESPONSES OF MULTIPLE SCLEROSIS PATIENTS PARTICIPATING IN THE PROMS SURVEY: IMPACT OF DISEASE-MODIFYING THERAPIES AND SUPPORT SERVICES ON PATIENT-REPORTED OUTCOMES
    Shields, Simon
    Parkes, Laura
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (11):
  • [8] Disease modifying therapies in multiple sclerosis
    Sharrack, B.
    Jenkins, T.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (05) : 532 - 534
  • [9] Disease modifying therapies in multiple sclerosis
    Khatri, BO
    McQuillen, MP
    NEUROLOGY, 2002, 59 (03) : 471 - 472
  • [10] Alopecia in Multiple Sclerosis Patients Treated with Disease Modifying Therapies
    Porwal, Mokshal H.
    Salter, Amber
    Patel, Dhruvkumar
    Obeidat, Ahmed Z.
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2022, 14
12345